{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T09:04:00Z","timestamp":1771664640244,"version":"3.50.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.thromres.2010.01.017","type":"journal-article","created":{"date-parts":[[2010,2,12]],"date-time":"2010-02-12T04:31:11Z","timestamp":1265949071000},"page":"243-245","source":"Crossref","is-referenced-by-count":13,"title":["Influence of anticoagulant therapy with vitamin K antagonists on plasma levels of coagulation factor VIII"],"prefix":"10.1016","volume":"126","author":[{"given":"Serena Maria","family":"Passamonti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Bucciarelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rossella","family":"Bader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ida","family":"Martinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.thromres.2010.01.017_bib1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1055\/s-0037-1613747","article-title":"in't Anker PS, Koopman MMW, Reitsma PH, Prins MH, van den Ende A et al. High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism","volume":"83","author":"Kraaijenhagen","year":"2000","journal-title":"Thromb Haemost"},{"issue":"5","key":"10.1016\/j.thromres.2010.01.017_bib2","first-page":"1040","article-title":"Absolute annual incidence of first event of venous thromboembolism and artherial vascular events in individuals with elevated FVIII:c. A prospective family cohort study","volume":"98","author":"Bank","year":"2007","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1016\/j.thromres.2010.01.017_bib3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1055\/s-0037-1613748","article-title":"Elevation of FVIII: C in venous thromboembolism is persistent and independent of the acute phase reaction","volume":"83","author":"O'Donnell","year":"2000","journal-title":"Thromb Haemost"},{"issue":"5","key":"10.1016\/j.thromres.2010.01.017_bib4","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1055\/s-0038-1656061","article-title":"High prevalence of elevated factor VIII levels in patients referred for thrombophilia screening: role of increased synthesis and relationship to the acute phase reaction","volume":"77","author":"O'Donnell","year":"1997","journal-title":"Thromb Haemost"},{"issue":"8","key":"10.1016\/j.thromres.2010.01.017_bib5","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.ejim.2007.06.036","article-title":"Relation between hemostetic parameters and prognostic\/predictive factors in breast cancer","volume":"19","author":"Yigit","year":"2008","journal-title":"Eur J Intern Med."},{"issue":"3","key":"10.1016\/j.thromres.2010.01.017_bib6","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/hep.20569","article-title":"Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests","volume":"41","author":"Tripodi","year":"2005","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.thromres.2010.01.017_bib7","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1055\/s-2003-38897","article-title":"Hemostasis during normal pregnancy and puerperium","volume":"29","author":"Hellgren","year":"2003","journal-title":"Sem Thromb Haemost."},{"issue":"4","key":"10.1016\/j.thromres.2010.01.017_bib8","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1046\/j.1365-2141.1997.1222936.x","article-title":"Epidemiology of coagulation factors, inhibithors and activation markers : the Third Glasgow MONICA Survey. I. Illustrative ranges by age, sex and hormone use","volume":"97","author":"Lowe","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2010.01.017_bib9","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0140-6736(64)90067-4","article-title":"Evidence for rebound \u201chypercoagulability\u201d after stopping anticoagulants","volume":"2","author":"Poller","year":"1964","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.thromres.2010.01.017_bib10","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1055\/s-0038-1649992","article-title":"Factor VIII:C levels during oral anticoagulation and after its withdrawal","volume":"74","author":"Palareti","year":"1995","journal-title":"Thromb Haemost"},{"issue":"6","key":"10.1016\/j.thromres.2010.01.017_bib11","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/00001721-199212000-00004","article-title":"Non vitamin-K-dependent clotting factors during oral anticoagulation treatment","volume":"3","author":"van Wersch","year":"1992","journal-title":"Blood Coagulat Fibrinol"},{"key":"10.1016\/j.thromres.2010.01.017_bib12","series-title":"Laboratory techniques in thrombosis. A manual","first-page":"107","article-title":"Factor VIII clotting activity","author":"Mannucci","year":"1999"},{"issue":"1","key":"10.1016\/j.thromres.2010.01.017_bib13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1055\/s-2005-863802","article-title":"Review of the clinical and diagnostic utility of laboratory tests for the detection of congenital thrombophilia","volume":"31","author":"Tripodi","year":"2005","journal-title":"Sem Thromb Haemost"},{"issue":"7","key":"10.1016\/j.thromres.2010.01.017_bib14","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1056\/NEJM200008173430702","article-title":"High plasma levels of factor VIII and the risk of recurrent venous thromboembolism","volume":"343","author":"Kyrle","year":"2000","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.thromres.2010.01.017_bib15","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00277-008-0626-1","article-title":"6 versus 30months anticoagulation for recurrent venous thrombosis in patients with factor VIII","volume":"88","author":"Eischer","year":"2008","journal-title":"Ann Hematol"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384810000459?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384810000459?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,25]],"date-time":"2019-05-25T18:48:41Z","timestamp":1558810121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384810000459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S0049384810000459"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2010.01.017","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}